Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001857552 | SCV002317879 | uncertain significance | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2021-09-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 180281). This variant has not been reported in the literature in individuals affected with BAG3-related conditions. This variant is present in population databases (rs730880053, ExAC 0.009%). This sequence change replaces valine with methionine at codon 108 of the BAG3 protein (p.Val108Met). The valine residue is weakly conserved and there is a small physicochemical difference between valine and methionine. |
Fulgent Genetics, |
RCV001857552 | SCV002797730 | uncertain significance | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000157120 | SCV000206843 | uncertain significance | Primary dilated cardiomyopathy | 2014-12-01 | no assertion criteria provided | clinical testing |